Topics

Articles

Substantial investments have been made, but beneficial results hard to identify, says ZS Associates

Life sciences marketers contend with a flood of new data sources—and the challenge of integrating them for meaningful results

Applying specialty-pharma techniques to a potentially mass-market drug

Healthcare research firm calls out the alarmist predictions over PCSK9s and other new drugs

Advent joins Thomas Lee Partners in ownership of the clinical, commercial outsourcer

The scale of the cardiovascular market pushes payers to demand quality outcomes data

Bloomberg BusinessWeek rakes over charitable copay programs

Company pursues ‘bench to bedside’ commercialization services

Site opens up a Facebook-like “Pages” to vendors and medical organizations